Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Megna

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 30, 2024
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis)L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapyL Sacchelli, F Filippi, A Balato, et al.
The Journal of Dermatological Treatment|August 20, 2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)D Orsini, M Megna, C Assorgi, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 30, 2024
Long-term effectiveness and tolerability of apremilast in patients with moderate-to-severe plaque psoriasis: A 5-year multicentre retrospective study-IL PSO (Italian landscape psoriasis)L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS)L Gargiulo, L Ibba, P Malagoli, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 7, 2023
PsoBioVax: A multicentric Italian case-control study of the immunological response to anti-SARS-CoV-2 vaccine among psoriatic patients under biological therapyL Sacchelli, F Filippi, A Balato, et al.
The Journal of Dermatological Treatment|August 20, 2024
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis)D Orsini, M Megna, C Assorgi, et al.
Pageof 7